PT-141

PT-141, also known as Bremelanotide, is a research-grade synthetic cyclic heptapeptide derived as a metabolite of Melanotan II. It functions as a non-selective melanocortin receptor agonist with particular affinity for MC3R and MC4R subtypes. Unlike vasoactive compounds that act peripherally, PT-141 operates centrally via the nervous system, making it a unique reference compound for studying neuroendocrine and central arousal pathways at the receptor level.

Available in 10mg vials. Every batch is HPLC tested and independently verified to a minimum of 99% purity. Certificate of Analysis available on request.

Research applications include:

Melanocortin receptor (MC1R–MC5R) agonism and binding kinetics studies

Central nervous system arousal signalling research models

Neuroendocrine function and hypothalamic pathway investigation

Peptide-mediated mood and behaviour modulation mechanism studies

Comparative research vs PDE5 inhibitors and peripheral vasoactive compounds

α-MSH analogue and pigmentation pathway research

Product specifications:

Form: Lyophilised powder

Purity: ≥99% (HPLC verified)

Storage: −20°C, protected from light and moisture

Available size: 10mg

Origin: UK warehouse, same day dispatch